New Results
Inflammasome-mediated antagonism of type I interferon enhances Rickettsia pathogenesis
Thomas P. Burke, Patrik Engström, Roberto A. Chavez, Joshua A. Fonbuena, Russell E. Vance, View ORCID ProfileMatthew D. Welch
doi: https://doi.org/10.1101/697573
Thomas P. Burke
1Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, 94720 USA
Patrik Engström
1Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, 94720 USA
Roberto A. Chavez
1Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, 94720 USA
2Howard Hughes Medical Institute
Joshua A. Fonbuena
1Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, 94720 USA
Russell E. Vance
1Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, 94720 USA
2Howard Hughes Medical Institute
Matthew D. Welch
1Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, 94720 USA
Article usage
Posted July 11, 2019.
Inflammasome-mediated antagonism of type I interferon enhances Rickettsia pathogenesis
Thomas P. Burke, Patrik Engström, Roberto A. Chavez, Joshua A. Fonbuena, Russell E. Vance, Matthew D. Welch
bioRxiv 697573; doi: https://doi.org/10.1101/697573
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8749)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12086)
- Cell Biology (17403)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16795)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11582)
- Neuroscience (60936)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10423)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)